The Patent Finder
BI

Biothera, Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

3 patents currently held

14 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4 more records may belong here and await a decision; they are not counted.

The next term ends in May 2028. from the record

Of the 14 now held by other companies, 14 name Hibercell Inc. as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
May 2028
Next term end
2
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.

Formerly held, still cited

Notable
Cited by 5 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2034.
now held by Hibercell, Inc.
Ends Feb 2034 · High confidence
Also notable
Renewed at every maintenance window since the 2011 grant; no more fees are due before its term ends in 2028.
now held by Hibercell, Inc.
Ends Oct 2028 · High confidence
Also notable
Granted 2017 and renewed at every maintenance window due so far. Protection runs to 2032. A terminal disclaimer caps this term to an earlier patent's.
now held by Hibercell, Inc.
Ends Sep 2032 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 10, 2027.

Recent changes

  • 1 term has ended since Aug 17, 2026

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 3 of 3

PatentTitleStatusExpiresConfidence
US 8,530,642Particulate-Soluble Glucan Preparation
In force
 · High confidence
In forceHigh confidence
US 8,859,759Particulate-Soluble Glucan Preparation
In force
 · Medium confidence
In forceMedium confidence
US 12,435,306Method for Setting Up an Apparatus for Biological Processes and Apparatus for Biological Processes
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 3: 14 patents in force now held by others · 7 patents ended · 2 applications pending · 16 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
5 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited